Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Fatigue, Fibromyalgia, Migraine, Muscular weakness
Clinical narrative: vision loss in my right eye; sudden onset of migraines; extreme fatigue; shortness of breath; muscle weakness; fibro myalgia flare up; balance issues; dizziness; elevation in blood sugar; This is a spontaneous report received from a Consumer or other non HCP.  A 58-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 13Apr2021 as dose 2, single (Lot number: GR8730) at the age of 58 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "hypertension" (unspecified if ongoing); "diabetes" (unspecified if ongoing); "fibromyalgia" (ongoing); "autoimmune response" (unspecified if ongoing), notes: unknown autoimmune response; "allergies" (unspecified if ongoing), notes: known allergies: yes. The patient took concomitant medications. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, prev dose lot number=8730ER,, prev dose lot unknown=False,, prev dose administration date=23Mar2021,, prev dose dose number=1,, prev dose vaccine location=Right arm), administration date: 23Mar2021, when the patient was 58-year-old, for covid-19 immunization. The following information was reported: BALANCE DISORDER (disability) with onset 01Jul2021, outcome "recovering", described as "balance issues"; DIZZINESS (disability) with onset 01Jul2021, outcome "recovering"; BLOOD GLUCOSE INCREASED (disability) with onset 01Jul2021, outcome "recovering", described as "elevation in blood sugar"; FATIGUE (disability) with onset 01Jul2021, outcome "recovering", described as "extreme fatigue"; FIBROMYALGIA (disability) with onset 01Jul2021, outcome "recovering", described as "fibro myalgia flare up"; MUSCULAR WEAKNESS (disability) with onset 01Jul2021, outcome "recovering", described as "muscle weakness"; DYSPNOEA (disability) with onset 01Jul2021, outcome "recovering", described as "shortness of breath"; MIGRAINE (disability) with onset 01Jul2021, outcome "recovering", described as "sudden onset of migraines"; BLINDNESS UNILATERAL (disability, medically significant) with onset 01Jul2021, outcome "recovering", described as "vision loss in my right eye". The events "vision loss in my right eye", "sudden onset of migraines", "extreme fatigue", "shortness of breath", "muscle weakness", "fibro myalgia flare up", "balance issues", "dizziness" and "elevation in blood sugar" required physician office visit. The patient underwent the following laboratory tests and procedures: Blood glucose: elevation; SARS-CoV-2 antibody test: Negative. Therapeutic measures were taken as a result of blindness unilateral, migraine, fatigue, dyspnoea, muscular weakness, fibromyalgia, balance disorder, dizziness, blood glucose increased.  Clinical course: It was unknown if other vaccine in four weeks. Regarding other medications in two weeks included likely some blood pressure. She had a sudden onset of migraines, vision loss in right eye, extreme fatigue, shortness of breath, elevation in blood sugar requiring medication, dizziness, muscle weakness, fibromyalgia flare up, balance issues.  Adeverse event resulted in doctor or other healthcare professional office clinic visit, Disability or permanent damage. Adverse event start date reported as 01Jul2021 and outcome reported as recovering and adverse event treatment included medications, PT, etc. No covid prior vaccination and tested for covid post vaccination.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202400059540 same patient/AE/drug, different dose;